The Latin America Aortic Stent Graft Market is witnessing steady expansion, supported by the growing demand for minimally invasive surgical techniques to treat complex vascular diseases such as abdominal and thoracic aortic aneurysms. Aortic stent grafts are critical in endovascular aneurysm repair (EVAR), offering reduced recovery time and lower procedural risks compared to open surgery. While the global aortic stent graft market was valued at USD 3.28 Billion in 2025, Latin America holds a significant share and is poised to benefit from the overall market growth projected at a CAGR of 5.80% from 2026 to 2035, reaching USD 5.76 Billion by 2035. Improving healthcare infrastructure and increasing cardiovascular disease prevalence are key regional growth drivers.

Emerging Trends Driving Market Growth

A prominent trend in the Latin America aortic stent graft market is the increasing adoption of endovascular repair procedures over traditional surgical approaches. Advancements in device design, including flexible graft materials and enhanced delivery systems, are improving procedural accuracy and patient outcomes.

Additionally, the integration of advanced imaging technologies and hybrid operating rooms is facilitating more precise interventions. Growing physician training programs and international collaborations are also strengthening technical expertise in vascular surgery across the region.

Growth Opportunities and Market Drivers

Rising incidences of hypertension, atherosclerosis, and aging-related vascular disorders are creating substantial demand for aortic stent graft procedures. Expanding access to specialized cardiac and vascular centers in countries such as Brazil, Mexico, and Argentina is further supporting market penetration.

Government initiatives aimed at improving cardiovascular care and increasing healthcare spending provide additional growth opportunities. The expanding private healthcare sector and medical tourism in select Latin American countries are also contributing to rising procedural volumes.

Challenges and Market Constraints

Despite promising growth prospects, the market faces challenges such as high device costs, reimbursement limitations, and disparities in healthcare access across rural and urban regions. Regulatory complexities and dependency on imported medical devices may also impact supply chains and pricing structures.

Claim your free sample report and review the detailed table of contents.

Competitive Landscape

The Latin America aortic stent graft market is competitive, with global manufacturers actively strengthening their distribution networks and product portfolios. Key players include:

Cook Medical, Inc.

W. L. Gore & Associates

MicroPort Scientific Corporation Inc.

Medtronic Plc.

Lombard Medical, Inc.

Endologix, Inc.

Terumo Corporation Inc.

Cardinal Health Inc.

Becton, Dickinson and Company

CryoLife Inc.

These companies focus on innovation, strategic partnerships, and regional expansion to enhance their market presence.